
Shares of CurveBeam AI CVB.AX rise as much as 6.8% to A$0.094, their biggest intraday pct gain since March 31
The medical equipment manufacturer says that it expects no material impact from tariffs announced by U.S. President Donald Trump
Co highlights that it conducts majority of its manufacturing activities within the U.S.
Shares of co fell 16.2% on Monday, in line with the markets sell-off seen globally amid recession fears
Shares of CurveBeam down 31.1%, YTD